The objective of this research is to determine the molecular basis of Alstrom Syndrome, a recessive disease characterized by conditions that are frequently observed in the general population. These include progressive aural and retinal degeneration, obesity, and Type II diabetes. Affected individuals normally die of heart disease or renal insufficiency in their second to fourth decade of life. Although it is unlikely that mutations within the Alstrom gene play a major role in any of these common complex disease traits, the real value of identifying the Alstr?m gene lies in the access it may provide to novel metabolic and regulatory pathways involved in neurosensory disease, obesity, type II diabetes, and related disorders. The Alstrom gene was localized to Chr. 2p13 by homozygosity mapping in a large French Acadian kindred. With the addition of results from two point linkage analysis of nine sporadic nuclear families segregating for the syndrome, the reported peak maximum lod score has increased from 3.84 to 5.75 (q = 0.00) at D2S327. Currently the minimal region containing the Alstrom gene is 6.1 cM in size.
The specific aims of this proposal include: (1) to narrow the genetic region continuing Alstrom to approximately 1 cM by identifying recombinant chromosomes in families segregating for Alstrom Syndrome; (2) to construct a high resolution, high density genetic map of candidate genes and anonymous markers of the Alstrom region with 1 marker every 1-200 kb; (3) to construct a physical P1 and BAC contig of the region; and (4) to identify the mutant transcript responsible for Alstrom Syndrome by examining ESTs and corresponding full length cDNAs expressed in appropriate tissues and by cDNA selection. The characteristics of deafness, blindness, and obesity have been described in a number of childhood syndromes, suggesting a basic defect in common developmental pathways. Locating and identifying the gene and the molecular defect causing Alstrom may give us insight into what those pathways are. Study of the gene product, its pattern of expression and how it impacts on other genes will lead to a better understanding of how normal biological pathways function.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD036878-02
Application #
2889565
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Mckeon, Catherine T
Project Start
1998-08-01
Project End
2001-05-31
Budget Start
1999-06-01
Budget End
2000-05-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Lindsey, Spencer; Brewer, Carmen; Stakhovskaya, Olga et al. (2017) Auditory and otologic profile of Alström syndrome: Comprehensive single center data on 38 patients. Am J Med Genet A 173:2210-2218
Dotan, Gad; Khetan, Vikas; Marshall, Jan D et al. (2017) Spectral-domain optical coherence tomography findings in Alström syndrome. Ophthalmic Genet 38:440-445
Citton, Valentina; Maffei, Pietro; Marshall, Jan D et al. (2016) Pituitary morphovolumetric changes in Alström syndrome. J Neuroradiol 43:195-9
Chakroun, Amine; Ben Said, Mariem; Ennouri, Amine et al. (2016) Long-term clinical follow-up and molecular testing for diagnosis of the first Tunisian family with Alström syndrome. Eur J Med Genet 59:444-51
Ozantürk, Ay?egül; Marshall, Jan D; Collin, Gayle B et al. (2015) The phenotypic and molecular genetic spectrum of Alström syndrome in 44 Turkish kindreds and a literature review of Alström syndrome in Turkey. J Hum Genet 60:1-9
Paisey, Richard B; Smith, Jamie; Carey, Catherine et al. (2015) Duration of Diabetes Predicts Aortic Pulse Wave Velocity and Vascular Events in Alström Syndrome. J Clin Endocrinol Metab 100:E1116-24
Marshall, Jan D; Muller, Jean; Collin, Gayle B et al. (2015) Alström Syndrome: Mutation Spectrum of ALMS1. Hum Mutat 36:660-8
Nadol Jr, Joseph B; Marshall, Jan D; Bronson, Roderick T (2015) Histopathology of the human inner ear in Alström's syndrome. Audiol Neurootol 20:267-72
Shenje, Lincoln T; Andersen, Peter; Halushka, Marc K et al. (2014) Mutations in Alström protein impair terminal differentiation of cardiomyocytes. Nat Commun 5:3416
Favaretto, Francesca; Milan, Gabriella; Collin, Gayle B et al. (2014) GLUT4 defects in adipose tissue are early signs of metabolic alterations in Alms1GT/GT, a mouse model for obesity and insulin resistance. PLoS One 9:e109540

Showing the most recent 10 out of 41 publications